Antiplatelet Use Prior to Anticoagulant Initiation in Patients With Atrial Fibrillation-Related Ischemic Stroke: An ELAN Trial Analysis

Antiplatelet Use Prior to Anticoagulant Initiation in Patients With Atrial Fibrillation-Related Ischemic Stroke: An ELAN Trial Analysis

Background and Purpose Antiplatelets are often used before direct oral anticoagulant (DOACs) initiation after an acute ischemic stroke related to atrial fibrillation (AF), but the evidence is weak. Here, we explored the risks and benefits of this approach. Methods A post-hoc analysis of ELAN (Early...

Full description

Saved in:
Bibliographic Details
Main Authors: Alexandros A. Polymeris, Masatoshi Koga, Daniel Strbian, Adhiyaman Vedamurthy, Manju Krishnan, Mattia Branca, Thomas Horvath, Martina Goeldlin, Gek Shim, Christoph Gumbinger, Liqun Zhang, Espen Saxhaug Kristoffersen, Philippe Desfontaines, Peter Vanacker, Angelika Alonso, Sven Poli, Ana Paiva Nunes, Nicoletta G. Caracciolo, Markus Kneihsl, Timo Kahles, Daria Giudici, Silja Räty, Marjaana Tiainen, Jesse Dawson, Urs Fischer, for the ELAN Investigators
Format: Article
Language:English
Published: Korean Stroke Society 2025-05-01
Series:Journal of Stroke
Subjects:
atrial fibrillation
ischemic stroke
anticoagulants
timing
antiplatelets
antiplatelet bridging
Online Access:http://j-stroke.org/upload/pdf/jos-2024-04322.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://j-stroke.org/upload/pdf/jos-2024-04322.pdf

Similar Items